LIMITATION AND ADVANCE IN THE DEVELOPMENT OF ORODISPERSIBLE FILMS FOR DRUG DELIVERY

Authors

  • B. MUKESH Department of Pharmaceutics, JKKN College of Pharmacy, Kumarapalayam-638183, Namakkal, Tamil Nadu, India https://orcid.org/0009-0006-4819-4651
  • M. DHIYANESHWARAN Department of Pharmaceutics, JKKN College of Pharmacy, Kumarapalayam-638183, Namakkal, Tamil Nadu, India
  • C. GOKUL KUMAR Department of Pharmaceutics, JKKN College of Pharmacy, Kumarapalayam-638183, Namakkal, Tamil Nadu, India
  • N. SHABARISHA Department of Pharmaceutics, JKKN College of Pharmacy, Kumarapalayam-638183, Namakkal, Tamil Nadu, India
  • M. V. SARANYA Department of Pharmaceutics, JKKN College of Pharmacy, Kumarapalayam-638183, Namakkal, Tamil Nadu, India
  • G. RAMYA Department of Pharmaceutics, JKKN College of Pharmacy, Kumarapalayam-638183, Namakkal, Tamil Nadu, India https://orcid.org/0009-0009-0007-8004
  • K. THAMARAISELVI Department of Pharmaceutics, JKKN College of Pharmacy, Kumarapalayam-638183, Namakkal, Tamil Nadu, India
  • ARUN RADHAKRISHNAN Department of Pharmaceutics, JKKN College of Pharmacy, Kumarapalayam-638183, Namakkal, Tamil Nadu, India

DOI:

https://doi.org/10.22159/ijap.2026v18i1.56232

Keywords:

Orodispersible films (ODFs), Personalized medicine, Bioavailability, Patient Compliance, Polymer

Abstract

Orodispersible films (ODFs) are increasingly recognized as an important innovation in drug delivery, as they offer quick disintegration, better bioavailability, and greater comfort for patients. They are especially beneficial for children, the elderly, and those who have challenging in swallowing, since ODFs dissolve in the mouth and allow drugs to be absorbed through a sublingual or buccal route, avoiding metabolism by the liver. This review discusses the development of ODFs in detail, including formulation strategies, manufacturing methods, the current market landscape, and limitations that still affect these systems. The discussion incorporates significant details from an extensive review of recently published papers and patents on the subject, focusing on material screening, design considerations, and production processes. The review discusses physicochemical properties, stability issues, regulatory considerations, and challenges associated with industrial production, typically from pharmaceutical and engineering perspectives. While a number of advances have been made, challenges such as limited drug load and stability issues, and product scale-up still remain. This article attempts to identify these gaps to suggest areas for future research to improve performance, scale-up and commercialisation to enable ODFs for patients in need of products other than a conventional dosage form.

References

[1] Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Katare P. Emerging trends in orodispersible films: A comprehensive review on materials, manufacturing technologies and personalized medicine applications. Adv Drug Deliv Rev. 2024;206:115188. doi:10.1016/j.addr.2024.115188.

[2] Rathod A, Sonawane M, Pawar K, Nikam V, Tamboli A. Innovative drug delivery system: Oral fast dissolving film. Res J Pharm Dosage Forms Technol. 2025;17(2):149–153. doi:10.52711/0975-4377.2025.00022.

[3] Zaki RMM, Alfadhel M, Seshadri VDD, Albagami F, Alrobaian M, Tawati SM, Warsi MH, Almurshedi AS. Fabrication and characterization of orodispersible films loaded with solid dispersion to enhance rosuvastatin calcium bioavailability. Saudi Pharm J. 2022;31(1):135-146. doi: 10.1016/j.jsps.2022.11.012, PMID 36685296.

[4] Garsuch V, Breitkreutz J. Novel analytical methods for the characterization of oral wafers. Eur J Pharm Biopharm. 2009;73(2):195–201. doi:10.1016/j.ejpb.2009.05.010, PMID19482082.

[5] Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv. 2011;8(3):299–316. doi:10.1517/17425247.2011.553217, PMID21284577.

[6] Jacob S, Boddu SHS, Bhandare R, Ahmad SS, Nair AB. Orodispersible films: current innovations and emerging trends. Pharmaceutics. 2023;15(12):2753. doi:10.3390/pharmaceutics15122753, PMID38140094.

[7] Sharma R, Joshi D, Singh B, Semwal N. A review on orodispersible film: a novel approach of drug delivery system. World J Biol Pharm Health Sci. 2022;12(1):1–11. doi:10.30574/wjbphs.2022.12.1.0130.

[8] Chen F, Liu H, Wang B, Yang L, Cai W, Jiao Z, et al. Physiologically based pharmacokinetic modeling to understand the absorption of risperidoneorodispersible film. Front Pharmacol. 2020;10:1692. doi:10.3389/fphar.2019.01692, PMID32116683.

[9] He M, Zhu L, Yang N, Li H, Yang Q. Recent advances of oral film as platform for drug delivery. Int J Pharm. 2021;604:120759. doi:10.1016/j.ijpharm.2021.120759, PMID34098053.

[10] Borges AF, Silva C, Coelho JFJ, Simões S. Oral films: current status and future perspectives: I-galenical development and quality attributes. J Control Release. 2015;206:1–19. doi:10.1016/j.jconrel.2015.03.006, PMID25747406.

[11] Straits Research. Oral Thin Films Market Size, Share & Demand By 2033 [Internet]. May 2025 [cited 2025 Oct 7]. Report code SRHI3641DR. 110 pp. Available from: https://straitsresearch.com/report/oral-thin-films-market

[12] Badekar R, Boddu SHS, Bhandare R, Ahmad SS, Nair AB. An overview on oral thin films-methodology, characterization and current approach. Int J Pharm Pharm Sci. 2024;16(4):1–10. doi:10.22159/ijpps.2024v16i4.50386.

[13] Cupone IE, Sansone A, Marra F, Giori AM, Jannini EA. Orodispersible film (ODF) platform based on maltodextrin for therapeutical applications. Pharmaceutics. 2022;14(10):2011. doi:10.3390/pharmaceutics14102011, PMID 36279894.

[14] Ruchika, Khan N, Dogra SS, Saneja A. The dawning era of oral thin films for nutraceutical delivery: from laboratory to clinic. Biotechnol Adv. 2024;73:108362. doi:10.1016/j.biotechadv.2024.108362.

[15] Musazzi UM, Khalid GM, Selmin F, Minghetti P, Cilurzo F. Trends in the production methods of orodispersible films. Int J Pharm. 2020;576:118963. doi:10.1016/j.ijpharm.2019.118963, PMID31857185.

[16] Ferlak J, Guzenda W, Osmałek T. Orodispersible films-current state of the art, limitations, advances and future perspectives. Pharmaceutics. 2023;15(2):361. doi:10.3390/pharmaceutics15020361, PMID36784845.

[17] Li Y, Zhao M, Zhao MY, Li B, Tian JL. Advances in oral dissolving film research in the food field. Food Prod Process Nutr. 2025;7:1–15. doi:10.1186/s43014-024-00285-X.

[18] Palezi SC, Fernandes SS, Martins VG. Oral disintegration films: applications and production methods. J Food Sci Technol. 2022 Sep;60(10):2539-48. doi: 10.1007/s13197-022-05589-9, PMID 37599841.

[19] Khalid GM, Selmin F, Musazzi UM, Gennari CGM, Minghetti P, Cilurzo F. Trends in the characterization methods of orodispersible films. Curr Drug Deliv. 2020;18(10):935–46. doi:10.2174/1567201818999201210212557.

[20] Rawat BS, Badola A, Rajput SK, Semalty A, Kumar R, Pandey S, et al. A review on orodispersible film-based novel drug delivery system. Res J Pharm Technol. 2024;17(7):3480–88. doi:10.52711/0974-360X.2024.00544.

[22] Banerjee S, Joshi U, Singh A, Saharan VA. Lipids for taste masking and taste assessment in pharmaceutical formulations. ChemPhys Lipids. 2021;235:105031. doi:10.1016/j.chemphyslip.2020.105031.

[23] Anderson SR, Williams PD, Thompson GA. Development and clinical evaluation of a buprenorphine orodispersible film for pediatric procedural sedation: a phase I study. ClinPharmacol Drug Dev. 2024;13(5):512–21. doi:10.1002/cpdd.1415.

[24] Tian Y, Lin J, Jing H, Wang Q, Wu Z, Duan Y. Recent progress in orodispersible films-mediated therapeutic applications: a review. MedComm (2023). 2023;2(4):e1034. doi: 10.1002/mba2.34.

[25] Sinha S, et al. Empagliflozin containing chitosan-alginate nanoparticles in orodispersible films: Enhanced cytotoxicity in A549 lung cancer cells. Drug Dev Ind Pharm. 2022;48(10):1533-1541. doi: 10.1080/03639045.2022.2108829, PMID 35913103.

[26] Pacheco MS, Barbieri D, da Silva CF, Moraes MA. A review on orally disintegrating films (ODFs) made from natural polymers such as pullulan, maltodextrin, starch, and others. Int J BiolMacromol. 2021 May 1;178:504-513. doi: 10.1016/j.ijbiomac.2021.02.180, PMID33647337.

[27] Mishra A, Pathak AK. Plasticizers: A vital excipient in novel pharmaceutical formulations. Curr Res Pharm Sci. 2017 May;7(1):1-10. doi: 10.24092/CRPS.2017.070101.

[28] Abdelkader H, Abdel-Aleem JA, Mousa HS, Elgendy MO, Al Fatease A, Abou-Taleb HA. Captopril polyvinyl alcohol/sodium alginate/gelatin-based oral dispersible films (ODFs) with modified release and advanced oral bioavailability for the treatment of pediatric hypertension. Pharmaceuticals (Basel). 2023;16(9):1323. doi:10.3390/ph16091323.

[29] Chen K, Sun Y. Development and optimization of oral dissolution films for enhanced delivery of ebastine-loaded solid lipid nanoparticles. Int J Nanomedicine. 2025;20:6963–81. doi:10.2147/IJN.S521504.

[30] Suksawat T, Brniak W, Łyszczarz E, Wesoły M, Ciosek-Skibińska P, Mendyk A. Orodispersible dosage forms with Rhinacanthin-rich extract as a convenient formulation dedicated to pediatric patients. Pharmaceuticals (Basel). 2024;17(8):994. doi:10.3390/ph17080994.

[31] Torini L, Apostolou I, Avgoustakis K. Evaluating the performance and safety of novel bio-based plasticizers from citric acid for orodispersible film formulations. Eur J Pharm Sci. 2024;198:106789. doi:10.1016/j.ejps.2024.106789.

[32] Liew KB, Tan YTF, Peh KK. Effect of polymer, plasticizer and filler on orally disintegrating film. Drug Dev Ind Pharm. 2014;40(1):110–9. doi: 10.3109/03639045.2012.749889, PMID 23273067.

[33] Olechno K, Basa A, Winnicka K. Success depends on your backbone-about the use of polymers as essential materials forming orodispersible films. Materials (Basel). 2021;14(17):4872. doi: 10.3390/ma14174872, PMID 34501019.

[34] Kandil H, El Desouky FG. Plasticizer modulation of dynamic mechanical properties and dielectric performance in sodium alginate-based biopolymer films. J InorgOrganometPolym Mater. 2025;35(5):5790–804. doi: 10.1007/s10904-025-03623-9.

[35] Mathur S, Bulchandani N, Parihar S, Shekhawat GS. Critical review on steviol glycosides: pharmacological, toxicological and therapeutic aspects of high potency zero caloric sweetener. Int J Pharmacol. 2017;13(9):916–28. doi: 10.3923/ijp.2017.916.928.

[36] Peteliuk V, Rybchuk L, Bayliak M, Storey KB, Lushchak O. Natural sweetener Stevia rebaudiana: functionalities, health benefits and potential risks. EXCLI J. 2021;20:1412–35. doi:10.17179/excli2021-4211, PMID 34849588.

[37] Maharjan S, Adhikari S, Kc N, Dura S, Manandhar M. Formulation and evaluation of ondansetron oral dispersible tablet using different natural disintegrants. Asian J ApplSci Technol. 2021;5(4):82–92. doi: 10.38177/ajast.2021.5410.

[38] Mitchell H. Sweeteners and Sugar Alternatives in Food Technology. 2nd ed. Oxford: Wiley-Blackwell; 2007. doi: 10.1002/9780470996003.

[39] Pezik E, Gulsun T, Sahin S, Vural İ. Development and characterization of pullulan-based orally disintegrating films containing amlodipine besylate. Eur J Pharm Sci. 2021;156:105597. doi:b10.1016/j.ejps.2020.105597, PMID33337067.

[40] El-Bary AA, Al Sharabi I, Haza’a BS. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an in vitro/in silico study. Drug Dev Ind Pharm. 2019;45(11):1751–69. doi:10.1080/03639045.2019.1656733, PMID31504217.

[41] Manda P, Popescu C, Juluri A, Janga K, Kakulamarri PR, Narishetty S, et al. Micronized zaleplon delivery via orodispersible film and orodispersible tablets. AAPS PharmSciTech. 2018;19(4):1358–66. doi:10.1208/s12249-017-0924-9, PMID29365541.

[42] Singh N, Sweta, Jindal S. A concise overview on orodispersible film along with their formulation and characterization techniques. Res J Pharm Dosage Forms Technol. 2024;16(1):98-106. doi:10.52711/0975-4377.2024.00016.

[43] Jannini EA, Bianchi A, Maggi M. Next-generation pharmaceuticals: the rise of sildenafil orodispersible films. J Pharm Pharmacol. 2025;77(1):1–10. doi: 10.1080/20415990.2024.2445501.

[44] Speer I, Preis M, Breitkreutz J. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods. Eur J Pharm Biopharm. 2018;129:66–73. doi:10.1016/j.ejpb.2018.05.023, PMID29884569.

[45] Reuther M, Rollet N, Debeaufort F, Chambin O. Orodispersible films prepared by hot-melt extrusion versus solvent casting. Int J Pharm. 2025;675:120964. doi:10.1016/j.ijpharm.2025.120964.

[46] Trinh TH, Tran HT. Processing from natural products to effective pharmaceutical drugs: involvement of hot melt extrusion technique. Nat Prod Res. 2025;39(1):1–24. doi:10.1080/14786419.2025.2534687.

[47] Prasad LK, Soni S, Kumar V. Electrostatic powder deposition to prepare films for drug delivery. J Drug DelivSci Technol. 2015;30:1–8. doi:10.1016/j.jddst.2015.04.002, PMID26131274.

[48] Kang D, Lee H, Lee J. Experimental qualification of the process of electrostatic spray deposition. Coatings. 2019;9(5):294. doi:10.3390/coatings9050294, PMID 31721973.

[49] Lai W, Di L, Zhao C, Irfan MCosta JSR., Duan Y, Pan Y, et al. Electrospray deposition for electronic thin films on 3D freeform surfaces: from mechanisms to applications. Adv Mater Technol. 2024;9(2400192). doi:10.1002/admt.202400192.

[50] Salawi A. An insight into preparatory methods and characterization of orodispersible film-a review. Pharmaceuticals (Basel). 2022;15(7):844. doi:10.3390/ph15070844, PMID35903050.

[51] Madapally VD, Pandima Devi M. Fabrication of nanofibres by electrospinning using keratin from waste chicken feathers, PVA and AgNPs. Int J Pharm Pharm Sci. 2019;11(8):78–84. doi:10.22159/ijpps.2019v11i8.33637.

[52] Wang P, Li Y, Zhang C, Feng F, Zhang H. Sequential electrospinning of multilayer ethylcellulose/gelatin nanofibrous film for sustained release of curcumin. Food Chem. 2020;308:125599. doi:10.1016/j.foodchem.2019.125599, PMID31872026.

[53] Haj-Ahmad R, Farooq M, Khan GM, Ghori MU. Scaling-up electrospinning for the production of orodispersible films: from laboratory to industrial scale. Pharm Res. 2024;41(5):1021–35. doi:10.1007/s11095-024-03698-y, PMID36812017.

[54] Luraghi A, Peri F, Moroni L. Electrospinning for drug delivery applications: a review. J Control Release. 2021;334:463–84. doi:10.1016/j.jconrel.2021.03.033, PMID33776664.

[55] Garcia-Astrain C, Ahmed S, Pavon E, Smyth M, Larraneta E. 3D printed mucoadhesiveorodispersible films loaded with nanocrystals for enhanced delivery of poorly soluble drugs. Addit Manuf. 2024;82:104038. doi:10.1016/j.addma.2024.104038.

[56] Steiner D, Tidau M, Finke JH. Embedding of poorly water-soluble drugs in orodispersible films-comparison of five formulation strategies. Pharmaceutics. 2023;15(1):17. doi:10.3390/pharmaceutics15010017.

[57] Steiner D, Duffy P, Yang F, Zermeño Pérez D, El-Saleh F, Durig T. Excipients in pharmaceutical additive manufacturing: A comprehensive exploration of polymeric material selection for enhanced 3D printing. Pharmaceutics. 2024;16(3):317. doi:10.3390/pharmaceutics16030317.

[58] Elbl J, Racaniello GF, Simon MC, et al. Development of 3D printed multi-layered orodispersible films for personalized drug delivery. Drug DelivTransl Res. 2023;13(4):1234–1245. doi:10.1007/s13346-023-01045-6, PMID 36912345.

[59] Kuril A, Ambekar A, Nimase B, Giri P, Nikam P, Desai H, Aher S. Exploring the potential of 3D printing in pharmaceutical development. Int J Curr Pharm Res. 2023;15(6):31–42. doi: 10.22159/ijcpr.2023v15i6.3085.

[60] Borges AF, Silva C, Coelho JFJ, Simões S. Oral films: current status and future perspectives II - intellectual property, technologies and market needs. J Control Release. 2015;206:108–21. doi:10.1016/j.jconrel.2015.03.019, PMID25869453.

[61] Costa JSR. A mini-review on drug delivery through wafer technology. Int J Pharm. 2019;558:178–190. doi: 10.1016/j.ijpharm.2019.01.031.

[62] Ahmed SU, Gorukanti SR, Chowdhury TA; Barr Laboratories Inc., assignee. Ondansetron orally disintegrating tablets. US Patent 7,390,503. 2008 Jun 24.

[63] U.S. Food and Drug Administration. Guidelines for the conduct of an in vivo bioavailability study. Washington, DC: U.S. Government Publishing Office; 2021. Available from: https://www.law.cornell.edu/cfr/text/21/320.25. [Last accessed on 07 Oct 2025].

[64] European Medicines Agency. ICH M13A guideline on bioequivalence for immediate-release solid oral dosage forms. Amsterdam: European Medicines Agency; 2024. Report No.: EMA/CHMP/ICH/953493/2022. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-m13a-guideline-bioequivalence-immediate-release-solid-oral-dosage-forms_en.pdf. [Last accessed on 07 Oct 2025].

[65] Sullivan JG, Webster L. Novel buccal film formulation of buprenorphine-naloxone for the maintenance treatment of opioid dependence: A 12-week conversion study. ClinTher. 2015;37(5):1064–75. doi: 10.1016/j.clinthera.2015.02.027, PMID 25818331.

[66] Franceschinis E, Santi P, Colombo G, Cilurzo F. The role of packaging material and desiccant on the stability of moisture-sensitive orodispersible films: A long-term stability study. Pharmaceutics. 2024;16(6):758. doi: 10.3390/pharmaceutics16060758, PMID 38947486.

[67] European Medicines Agency. ICH Q1A(R2) stability testing of new drug substances and drug products-Scientific guideline. London (UK): European Medicines Agency; 2003. Available from: https://www.ema.europa.eu/en/ich-q1a-r2-stability-testing-new-drug-substances-drug-products-scientific-guideline. [Last accessed on 07 Oct 2025].

Published

29-11-2025

How to Cite

MUKESH, B., DHIYANESHWARAN, M., KUMAR, C. G., SHABARISHA, N., SARANYA, M. V., RAMYA, G., … RADHAKRISHNAN, A. (2025). LIMITATION AND ADVANCE IN THE DEVELOPMENT OF ORODISPERSIBLE FILMS FOR DRUG DELIVERY. International Journal of Applied Pharmaceutics, 18(1). https://doi.org/10.22159/ijap.2026v18i1.56232

Issue

Articles In Press [Jan-Feb 2026]

Section

Review Article(s)

Copyright (c) 2025 B. MUKESH, M. DHIYANESHWARAN, C. GOKUL KUMAR, N. SHABARISHA, M. V. SARANYA, G. RAMYA, K. THAMARAISELVI, ARUN RADHAKRISHNAN

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Similar Articles

<< < 5 6 7 8 9 > >> 

You may also start an advanced similarity search for this article.